title: Use of tissue plasminogen activator for femoral artery thrombosis following transcatheter coil occlusion of patent ductus arteriosus.
abstract: Femoral artery thrombosis is an uncommon but potentially serious complication following pediatric cardiac catheterization. Management options include heparin infusion, thrombolytic therapy, and surgical thrombectomy. The use of thrombolytic agents following coil occlusion of shunts, collaterals, and patent ductus arteriosus (PDA) may be successful in resolving the femoral arterial thrombosis but may also reopen the device-occluded vessel. We report the successful use of tissue plasminogen activator for management of femoral artery thrombosis in a child following transcatheter PDA coil occlusion in which the PDA remained occluded.
authors.affiliation: Lillie Frank Abercrombie Section of Cardiology, Department of Diagnostic Imaging, Texas Children's Hospital, Baylor College of Medicine, 6621 Fannin, MC 19345-C, Houston, TX 77030, USA.
authors.forename: K M
authors.initials: KM
authors.lastname: Carlson
authors.forename: J M
authors.initials: JM
authors.lastname: Rutledge
authors.forename: B R
authors.initials: BR
authors.lastname: Parker
authors.forename: R G
authors.initials: RG
authors.lastname: Grifka
mesh_terms: D001783:Blood Flow Velocity; D006328:Cardiac Catheterization; D002675:Child, Preschool; D015897:Comorbidity; D004374:Ductus Arteriosus, Patent / Q000453:epidemiology / Q000628:therapy*; D004621:Embolization, Therapeutic; D005263:Femoral Artery / Q000000981:diagnostic imaging / Q000503:physiopathology; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D010855:Pierre Robin Syndrome / Q000453:epidemiology; D015912:Thrombolytic Therapy; D013927:Thrombosis / Q000188:drug therapy*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*; D018615:Ultrasonography, Doppler, Color; D018617:Ultrasonography, Doppler, Pulsed
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator